Advanced search
Publication Cover
Journal of Medical Economics Volume 5, 2002 - Issue 1-4
Submit an article Journal homepage
144
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Modelling the economic impact of recombinant activated Factor VII and activated prothrombin-complex concentrate in the treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX at a comprehensive care centre in the UK

Isaac A O Odeyemi CATALYST Health Economics Consultants, Northwood, Middlesex, UK.
&
Julian F Guest CATALYST Health Economics Consultants, Northwood, Middlesex, UK.Correspondence[email protected]
Pages 51-64 | Accepted 25 Apr 2002, Published online: 02 Dec 2008

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Isaac A. O. Odeyemi & Anne M. Danø. (2009) Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis. Current Medical Research and Opinion 25:1, pages 239-250.
Read now
Jennifer M Stephens, Ashish V Joshi, Michael Sumner & Marc F Botteman. (2007) Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors. Expert Opinion on Pharmacotherapy 8:8, pages 1127-1136.
Read now
Sandro B Rizoli & Talat Chughtai. (2006) The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage. Expert Opinion on Biological Therapy 6:1, pages 73-81.
Read now
S Dundar, B Zülfikar, K Kavakli, C Gönen, H Zülfikar, D Yilmaz, WM Hart, A Sümen, S Tuna & M Karamalis. (2005) A cost evaluation of treatment alternatives in mild-to-moderate bleeding episodes in haemophilia patients with inhibitors in Turkey. Journal of Medical Economics 8:1-4, pages 46-54.
Read now
IAO Odeyemi, PW Friederich & M Levi. (2004) Economic impact of recombinant activated factor VII in the control of bleeds associated with abdominal prostatectomy. Journal of Medical Economics 7:1-4, pages 107-115.
Read now

Articles from other publishers (12)

Maria del Carmen Rodríguez-Zepeda, Lourdes González, Amalia Bravo, Teresa Pompa, Salvador Silva, Rogelio Paredes, Jaime García, Mafalda Ramos, Lars Wilkinson & Mark Lamotte. (2018) Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico. Value in Health Regional Issues 17, pages 164-173.
Crossref
Lucia S. D'Angiolella, Paolo A. Cortesi, Angiola Rocino, Antonio Coppola, Hamisa J. Hassan, Adele Giampaolo, Luigi P. Solimeno, Alessandra Lafranconi, Mariangela Micale, Sveva Mangano, Giacomo Crotti, Federica Pagliarin, Giancarlo Cesana & Lorenzo G. Mantovani. (2018) The socioeconomic burden of patients affected by hemophilia with inhibitors. European Journal of Haematology 101:4, pages 435-456.
Crossref
V. Jimenez-Yuste, R. Núñez, J. A. Romero, B. Montoro & B. Espinós. (2013) Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain. Haemophilia 19:6, pages 841-846.
Crossref
M. A. ESCOBAR. (2010) Health economics in haemophilia: a review from the clinician’s perspective. Haemophilia 16:s3, pages 29-34.
Crossref
C. KNIGHT, A. M. DANØ & T. KENNEDY‐MARTIN. (2010) A Rebuttal to the Commentary of J. W. Hay and Z.‐Y. Zhou. Haemophilia 2009; DOI:10.1111/j.1365‐2516.2009.02117.x: “Commentary on Knight et al. : A systematic review of the cost‐effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors” . Haemophilia 16:2, pages 369-371.
Crossref
M. N. D. DI MINNO, G. DI MINNO, M. DI CAPUA, A. M. CERBONE & A. COPPOLA. (2009) Cost of care of haemophilia with inhibitors. Haemophilia 16:1.
Crossref
C. KNIGHT, A. M. DANØ & T. KENNEDY-MARTIN. (2009) A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors. Haemophilia 15:2, pages 405-419.
Crossref
C. W. YOU, S. Y. LEE & S. K. PARK. (2009) Cost and effectiveness of treatments for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors in Korea. Haemophilia 15:1, pages 217-226.
Crossref
M. C OZELO, P. R VILLAÇA, J. O. S. C DE ALMEIDA, T. M. F BUENO, P. A. P DE MIRANDA, W. M HART & M KARAMALIS. (2007) A cost evaluation of treatment alternatives for mild-to-moderate bleeding episodes in patients with haemophilia and inhibitors in Brazil. Haemophilia 13:5, pages 462-469.
Crossref
Katherine A Lyseng-Williamson & Greg L Plosker. (2007) Recombinant Factor VIIa (Eptacog Alfa). PharmacoEconomics 25:12, pages 1007-1029.
Crossref
Karin Berger & Wolfgang Schramm. (2006) Der Einsatz von Gerinnungsfaktoren in der Hämophilie-Therapie. Gesundheitsökonomische Aspekte. Pharmazie in unserer Zeit 35:1, pages 66-73.
Crossref
Alec H. Miners. 2005. Textbook of Hemophilia. Textbook of Hemophilia 351 358 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.